
exenatide (CHEM042793)
| Record Information | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||||||||
| Creation Date | 2016-06-03 10:12:16 UTC | ||||||||||||||||||
| Update Date | 2016-11-09 01:22:48 UTC | ||||||||||||||||||
| Accession Number | CHEM042793 | ||||||||||||||||||
| Identification | |||||||||||||||||||
| Common Name | exenatide | ||||||||||||||||||
| Class | Small Molecule | ||||||||||||||||||
| Description | Exenatide, sold under the brand name Byetta and Bydureon among others, is a medication used to treat diabetes mellitus type 2. It is used together with diet, exercise, and potentially other antidiabetic medication. It is a treatment option after metformin and sulfonylureas. It is given by injection under the skin within an hour before the first and last meal of the day. A once-weekly injection version is also available.Common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection. Other serious side effects may include medullary thyroid cancer, angioedema, pancreatitis, and kidney injury. Use in pregnancy and breastfeeding is of unclear safety. Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing insulin release from the pancreas and decreases excessive glucagon release.Exenatide was approved for medical use in the United States in 2005. In 2017, it was the 260th most commonly prescribed medication in the United States, with more than one million prescriptions. | ||||||||||||||||||
| Contaminant Sources |
| ||||||||||||||||||
| Contaminant Type | Not Available | ||||||||||||||||||
| Chemical Structure | |||||||||||||||||||
| Synonyms |
| ||||||||||||||||||
| Chemical Formula | C184H282N50O60S | ||||||||||||||||||
| Average Molecular Mass | 4186.630 g/mol | ||||||||||||||||||
| Monoisotopic Mass | 4184.027 g/mol | ||||||||||||||||||
| CAS Registry Number | 141758-74-9 | ||||||||||||||||||
| IUPAC Name | Not Available | ||||||||||||||||||
| Traditional Name | Not Available | ||||||||||||||||||
| SMILES | CCC(C)C(N=C(O)C(CC1=CC=CC=C1)N=C(O)C(CC(C)C)N=C(O)C(CCCNC(N)=N)N=C(O)C(N=C(O)C(C)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(CCSC)N=C(O)C(CCC(O)=N)N=C(O)C(CCCCN)N=C(O)C(CO)N=C(O)C(CC(C)C)N=C(O)C(CC(O)=O)N=C(O)C(CO)N=C(O)C(N=C(O)C(CC1=CC=CC=C1)N=C(O)C(N=C(O)CN=C(O)C(CCC(O)=O)N=C(O)CN=C(O)C(N)CC1=CN=CN1)C(C)O)C(C)O)C(C)C)C(O)=NC(CCC(O)=O)C(O)=NC(CC1=CNC2=CC=CC=C12)C(O)=NC(CC(C)C)C(O)=NC(CCCCN)C(O)=NC(CC(O)=N)C(O)=NCC(O)=NCC(=O)N1CCCC1C(O)=NC(CO)C(O)=NC(CO)C(O)=NCC(O)=NC(C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)N1CCCC1C(O)=NC(CO)C(O)=N | ||||||||||||||||||
| InChI Identifier | InChI=1S/C184H282N50O60S/c1-16-94(10)147(178(289)213-114(52-58-144(257)258)163(274)218-121(73-101-77-195-105-39-24-23-38-103(101)105)168(279)215-116(68-90(2)3)165(276)205-107(41-26-28-61-186)158(269)219-122(75-134(189)243)154(265)198-79-135(244)196-83-139(248)231-63-30-43-129(231)175(286)225-127(87-238)174(285)223-125(85-236)155(266)200-80-136(245)202-96(12)181(292)233-65-32-45-131(233)183(294)234-66-33-46-132(234)182(293)232-64-31-44-130(232)176(287)222-124(84-235)150(190)261)229-170(281)119(71-99-34-19-17-20-35-99)217-166(277)117(69-91(4)5)214-159(270)108(42-29-62-194-184(191)192)212-177(288)146(93(8)9)228-151(262)95(11)203-156(267)111(49-55-141(251)252)208-161(272)112(50-56-142(253)254)209-162(273)113(51-57-143(255)256)210-164(275)115(59-67-295-15)211-160(271)110(47-53-133(188)242)207-157(268)106(40-25-27-60-185)206-172(283)126(86-237)224-167(278)118(70-92(6)7)216-169(280)123(76-145(259)260)220-173(284)128(88-239)226-180(291)149(98(14)241)230-171(282)120(72-100-36-21-18-22-37-100)221-179(290)148(97(13)240)227-138(247)82-199-153(264)109(48-54-140(249)250)204-137(246)81-197-152(263)104(187)74-102-78-193-89-201-102/h17-24,34-39,77-78,89-98,104,106-132,146-149,195,235-241H,16,25-33,40-76,79-88,185-187H2,1-15H3,(H2,188,242)(H2,189,243)(H2,190,261)(H,193,201)(H,196,244)(H,197,263)(H,198,265)(H,199,264)(H,200,266)(H,202,245)(H,203,267)(H,204,246)(H,205,276)(H,206,283)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,271)(H,212,288)(H,213,289)(H,214,270)(H,215,279)(H,216,280)(H,217,277)(H,218,274)(H,219,269)(H,220,284)(H,221,290)(H,222,287)(H,223,285)(H,224,278)(H,225,286)(H,226,291)(H,227,247)(H,228,262)(H,229,281)(H,230,282)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H4,191,192,194) | ||||||||||||||||||
| InChI Key | HTQBXNHDCUEHJF-UHFFFAOYSA-N | ||||||||||||||||||
| Chemical Taxonomy | |||||||||||||||||||
| Description | belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues. | ||||||||||||||||||
| Kingdom | Organic compounds | ||||||||||||||||||
| Super Class | Organic Polymers | ||||||||||||||||||
| Class | Polypeptides | ||||||||||||||||||
| Sub Class | Not Available | ||||||||||||||||||
| Direct Parent | Polypeptides | ||||||||||||||||||
| Alternative Parents |
| ||||||||||||||||||
| Substituents |
| ||||||||||||||||||
| Molecular Framework | Aromatic heteropolycyclic compounds | ||||||||||||||||||
| External Descriptors | Not Available | ||||||||||||||||||
| Biological Properties | |||||||||||||||||||
| Status | Detected and Not Quantified | ||||||||||||||||||
| Origin | Not Available | ||||||||||||||||||
| Cellular Locations | Not Available | ||||||||||||||||||
| Biofluid Locations | Not Available | ||||||||||||||||||
| Tissue Locations | Not Available | ||||||||||||||||||
| Pathways | Not Available | ||||||||||||||||||
| Applications | Not Available | ||||||||||||||||||
| Biological Roles | Not Available | ||||||||||||||||||
| Chemical Roles | Not Available | ||||||||||||||||||
| Physical Properties | |||||||||||||||||||
| State | Not Available | ||||||||||||||||||
| Appearance | Not Available | ||||||||||||||||||
| Experimental Properties |
| ||||||||||||||||||
| Predicted Properties |
| ||||||||||||||||||
| Spectra | |||||||||||||||||||
| Spectra | Not Available | ||||||||||||||||||
| Toxicity Profile | |||||||||||||||||||
| Route of Exposure | Not Available | ||||||||||||||||||
| Mechanism of Toxicity | Not Available | ||||||||||||||||||
| Metabolism | Not Available | ||||||||||||||||||
| Toxicity Values | Not Available | ||||||||||||||||||
| Lethal Dose | Not Available | ||||||||||||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||||||||||||
| Uses/Sources | Not Available | ||||||||||||||||||
| Minimum Risk Level | Not Available | ||||||||||||||||||
| Health Effects | Not Available | ||||||||||||||||||
| Symptoms | Not Available | ||||||||||||||||||
| Treatment | Not Available | ||||||||||||||||||
| Concentrations | |||||||||||||||||||
| Not Available | |||||||||||||||||||
| External Links | |||||||||||||||||||
| DrugBank ID | Not Available | ||||||||||||||||||
| HMDB ID | HMDB0252144 | ||||||||||||||||||
| FooDB ID | Not Available | ||||||||||||||||||
| Phenol Explorer ID | Not Available | ||||||||||||||||||
| KNApSAcK ID | Not Available | ||||||||||||||||||
| BiGG ID | Not Available | ||||||||||||||||||
| BioCyc ID | Not Available | ||||||||||||||||||
| METLIN ID | Not Available | ||||||||||||||||||
| PDB ID | Not Available | ||||||||||||||||||
| Wikipedia Link | Exenatide | ||||||||||||||||||
| Chemspider ID | 78432866 | ||||||||||||||||||
| ChEBI ID | Not Available | ||||||||||||||||||
| PubChem Compound ID | 53396299 | ||||||||||||||||||
| Kegg Compound ID | Not Available | ||||||||||||||||||
| YMDB ID | Not Available | ||||||||||||||||||
| ECMDB ID | Not Available | ||||||||||||||||||
| References | |||||||||||||||||||
| Synthesis Reference | Not Available | ||||||||||||||||||
| MSDS | Not Available | ||||||||||||||||||
| General References | Not Available | ||||||||||||||||||